Pregnancy
and Inflammatory Bowel Disease |
||
Inflammatory bowel disease (IBD) does not affect the outcome of pregnancy and more than 80% of women with IBD are able to have full-term healthy babies. The incidence of congenital abnormalities, low birth weight and spontaneous miscarriage is no greater than would occur in the general population. Patients with severe disease requiring surgery have an increased risk of complications but with the use of intravenous feeding (TPN), the outcome has been much more successful. The effects of pregnancy on IBD The risk of the disease relapsing during pregnancy is around 33%, which is no higher than the rate of relapse in patients who are not pregnant. Relapses tend to be more common in the first trimester (3 months) and can be more severe following delivery - possibly due to a sudden fall in the hormone levels. The course of the disease during pregnancy usually relates to disease activity at the time of conception. Therefore, it is recommended that you do not try to become pregnant when the disease is active as it may worsen. Ileostomy patients may have trouble with the function of the stoma in the second trimester (6 months+) due to displacement by the growing foetus (reported incidence of obstruction is 10% but therefore 90% of patients do not have problems). If this complication occurs, the patient develops abdominal pain and the stoma ceases to function. The effect of drugs on pregnancy and the foetus Supplements of folic acid are recommended during pregnancy especially when patients are given Salazopyrin which causes levels to fall in the body. Certain antibiotics, such as Metronidazole, should not be used in the first trimester of pregnancy and only thereafter for severe perianal disease. Most antibiotics also tend to pass into breast milk. However, if the doctor believes that these medicines are essential to control the IBD, it is not necessary to stop breast feeding as the levels in breast milk are less than the usual doses given to babies. Dietary treatment Investigations during pregnancy As mentioned previously, the majority of patients experience a remission of their disease during pregnancy and require no more intervention than the normal ultrasound scans. However, if investigations do need to be performed Nuclear Scans, (white cell scans), cause much less exposure to radiation and are very useful in monitoring the disease progress. MRI scans do not cause any exposure to radiation. Many patients are concerned about passing their disease on to their children. There is a small chance of this happening - around 8-9% of children of parents with Crohn's disease may develop the disease at some point in their lives, therefore 92% of children will not, so this should not deter you from having children. General care during pregnancy | ||